Clinical Trial

The Role of POLE Mutation in High Risk Endometrial Cancer.

Name: The Role of POLE Mutation in High Risk Endometrial Cancer. — clinical trial record (NCT07114653)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting

View on ClinicalTrials.gov →

Summary

The actual role of POLE mutations in high-risk endometrial cancer is undetermined. The main question it aims to answer is: What is the prevalence of POLE mutations in high-risk endometrial cancer case? What is the impact of POLE mutations in real world high-risk endometrial cancer case?

Trial Details

NCT Number	NCT07114653
Lead Sponsor	Far Eastern Memorial Hospital
Conditions	Endometrial Neoplasms
Enrollment	150 participants
Start Date	2025-09-01
Primary Completion	2026-12-31 (estimated)
Study Completion	2026-12-31 (estimated)
Updated on ClinicalTrials.gov	2025-08-11